SuperworthKestra Medical Technologies EPS KMTS
Diluted earnings per share by quarter and over the last twelve months, from 2024.
- Last 12 months, to Jul 31, 2026
- −$2.67
- Latest quarter, Q1 FY27
- −$0.75
- Fiscal year 2026
- −$2.42
Kestra Medical Technologies' earnings per share was −$2.67 over the twelve months to Jul 31, 2026.
In its latest quarter, Q1 FY27, it was −$0.75.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | −$2.42 | n/a |
| FY2025 | −$4.97 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | −$0.75 | n/a | −$2.67 | |
| Q4 FY26 | −$0.67 | n/a | −$2.42 | |
| Q3 FY26 | −$0.61 | n/a | −$3.16 | |
| Q2 FY26 | −$0.64 | n/a | −$3.80 | |
| Q1 FY26 | −$0.50 | n/a | −$4.35 | |
| Q4 FY25 | −$1.41 | n/a | −$4.97 | |
| Q3 FY25 | −$1.25 | n/a | n/a | |
| Q2 FY25 | −$1.19 | n/a | n/a | |
| Q1 FY25 | −$1.12 | n/a | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Kestra Medical Technologies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| KMTSKestra Medical Technologies | −$2.67 | |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| EYENational Vision | $0.61 | |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| CDRECadre | $0.81 | −14% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| BVSBioventus | $0.77 | |
| STAAStaar Surgical | $0.07 | |
| IRMDIradimed | $1.79 | +10% a year |
| ATRCAtriCure | $0.21 | |
| WRBYWarby Parker | $0.07 | |
| Peer median | $0.79 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Kestra Medical Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.